CA2010982A1 - Promotion de l'osteogenese par l'utilisation de derives de vitamine d - Google Patents

Promotion de l'osteogenese par l'utilisation de derives de vitamine d

Info

Publication number
CA2010982A1
CA2010982A1 CA2010982A CA2010982A CA2010982A1 CA 2010982 A1 CA2010982 A1 CA 2010982A1 CA 2010982 A CA2010982 A CA 2010982A CA 2010982 A CA2010982 A CA 2010982A CA 2010982 A1 CA2010982 A1 CA 2010982A1
Authority
CA
Canada
Prior art keywords
vitamin
derivatives
osteogenesis promotion
hydrogen atom
hydroxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2010982A
Other languages
English (en)
Other versions
CA2010982C (fr
Inventor
Toshio Matsumoto
Yasuho Nishii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CA2010982A1 publication Critical patent/CA2010982A1/fr
Application granted granted Critical
Publication of CA2010982C publication Critical patent/CA2010982C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002010982A 1989-02-28 1990-02-27 Promotion de l'osteogenese par l'utilisation de derives de vitamine d Expired - Fee Related CA2010982C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP48098/1989 1989-02-28
JP4809889 1989-02-28

Publications (2)

Publication Number Publication Date
CA2010982A1 true CA2010982A1 (fr) 1990-08-31
CA2010982C CA2010982C (fr) 2000-06-13

Family

ID=12793841

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010982A Expired - Fee Related CA2010982C (fr) 1989-02-28 1990-02-27 Promotion de l'osteogenese par l'utilisation de derives de vitamine d

Country Status (6)

Country Link
US (1) US5053401A (fr)
EP (1) EP0385446B1 (fr)
AT (1) ATE131061T1 (fr)
CA (1) CA2010982C (fr)
DE (1) DE69023939T2 (fr)
HK (1) HK1005015A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
AU666529B2 (en) * 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
KR960013798B1 (ko) * 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 평면 도파로형 공간 스위치
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
EP0676951B1 (fr) * 1992-12-29 2002-04-17 HOLICK, Michael F Utilisation de glycosides de vitamine d pour le traitement ou la prevention de l'osteoporose
WO1999040588A1 (fr) * 1998-02-03 1999-08-12 Siemens Aktiengesellschaft Accumulateur de pression et procede de mise a disposition d'un fluide sous pression
AUPP794898A0 (en) * 1998-12-24 1999-01-28 Garvan Institute Of Medical Research Transgenic animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332841C (fr) * 1984-11-27 1994-11-01 Noboru Kubodera Derives de vitamine d et procede de production
JPS61267550A (ja) 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体

Also Published As

Publication number Publication date
EP0385446A2 (fr) 1990-09-05
EP0385446B1 (fr) 1995-12-06
DE69023939D1 (de) 1996-01-18
ATE131061T1 (de) 1995-12-15
US5053401A (en) 1991-10-01
EP0385446A3 (fr) 1991-10-30
CA2010982C (fr) 2000-06-13
HK1005015A1 (en) 1998-12-18
DE69023939T2 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
IE890906L (en) Method of lowering the blood pressure
AU691476B2 (en) Injectable taxane derivative based compositions
AU8682191A (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
EP0488513A3 (fr) Utilisation des derivés dioxabicyclo [3.3.0]octanes pour l'obtention d'un médicament destiné à l'inhibition du métabolisme du cholestérol.
CA2010982A1 (fr) Promotion de l'osteogenese par l'utilisation de derives de vitamine d
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
TW223016B (fr)
AU575342B2 (en) Gamma - butyrolactone derivatives
NZ236032A (en) Napthacenedione derivatives, their preparation and pharmaceutical compositions
RU2091378C1 (en) 7-acyl-3-substituted carbamoylhydroxycephems, methods of their synthesis, substituted carbamoylhydroxy-3-cephems, methods of their synthesis and antibacterial composition
AU1254188A (en) Disaccharide derivatives
IE893258L (en) New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
GR3031767T3 (en) Cyclopropane derivatives and antiviral agents containing the same.
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
AP9901567A0 (en) Steroids substituted in composition 11, their preparation process, their use as medicaments and the pharmaceutical compounds containing them.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
IL95377A0 (en) Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed